dr. eng: re-initiating bevacizumab after multiple lines of treatment
Published 9 years ago • 69 plays • Length 0:31Download video MP4
Download video MP3
Similar videos
-
0:43
dr. chung: would you consider re-initiating bevacizumab in pts with multiple lines of treatment?
-
3:58
dr. cathy eng on bevacizumab plus folfoxiri for patients with mcrc
-
2:27
dr. eng: fourth-line treatment for progressive disease
-
0:34
dr. eng: second-line options to prolong survival
-
5:02
the rationale for folfox and bevacizumab in mcrc
-
4:25
adjuvant chemotherapy bevacizumab for ovarian cancer
-
0:26
dr. eng: egfr-directed therapy and mutational status
-
1:05
dr. eng: second egfr-directed therapy and mutational status
-
0:48
rationale for combining atezolizumab/bevacizumab in mrcc
-
0:30
dr. eng: how to prolong survival
-
4:01
personal experience with bevacizumab
-
1:00
dr. kris on the impact of bevacizumab biosimilars in lung cancer
-
6:00
metastatic colorectal cancer: multiple lines of therapy
-
2:24
how avastin (bevacizumab) targeted therapy treats advanced cancer
-
1:36
dr. rugo on the efficacy of bevacizumab in breast cancer
-
18:04
why has everything beyond bevacizumab failed in angiogenesis inhibition?
-
5:39
use of bevacizumab for lung cancer
-
1:19
dr. bekaii-saab discusses an analysis of bevacizumab or cetuximab for crc
-
1:22
tanios bekaii-saab, md: experience with patients on bevacizumab plus chemotherapy